Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Bulletin Du Cancer
|
July 26, 2025
[Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology]
Pablo Berlanga, Claudia Pasqualini, Marion Gambart, et al.
Cancer Medicine
|
February 6, 2015
Detection of tumor ALK status in neuroblastoma patients using peripheral blood
Valérie Combaret, Isabelle Iacono, Angela Bellini, et al.
Journal of Pediatric Hematology/Oncology
|
May 7, 2008
FDG PET and evaluation of posttherapeutic residual tumors in pediatric oncology: preliminary experience
Nicolas André, Alexandre Fabre, Cécile Colavolpe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 24, 2006
Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology
Isabelle Flandin, Olivier Hartmann, Jean Michon, et al.
Pediatric Blood & Cancer
|
July 12, 2011
A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age
Sylvie Monnereau-Laborde, Caroline Munzer, Dominique Valteau-Couanet, et al.
Haematologica
|
March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study
Anne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
Pediatric Blood & Cancer
|
August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study
Cyril Lervat, Anne Auperin, Catherine Patte, et al.
Pediatric Blood & Cancer
|
October 24, 2020
Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome
Ida Russo, Christine Levy-Gabriel, Axelle Dupont, et al.
Pediatric Blood & Cancer
|
November 9, 2010
Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP)
Fousseyni Traoré, Carole Coze, Jean-Jacques Atteby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2005
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol
Dominique Valteau-Couanet, Jean Michon, Andrée Boneu, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Bulletin Du Cancer
|
July 26, 2025
[Treatment guidelines for patients with relapsed/progressive high-risk neuroblastoma from the Neuroblastoma Committee of the French Society of Pediatric Oncology]
Pablo Berlanga, Claudia Pasqualini, Marion Gambart, et al.
Cancer Medicine
|
February 6, 2015
Detection of tumor ALK status in neuroblastoma patients using peripheral blood
Valérie Combaret, Isabelle Iacono, Angela Bellini, et al.
Journal of Pediatric Hematology/Oncology
|
May 7, 2008
FDG PET and evaluation of posttherapeutic residual tumors in pediatric oncology: preliminary experience
Nicolas André, Alexandre Fabre, Cécile Colavolpe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 24, 2006
Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology
Isabelle Flandin, Olivier Hartmann, Jean Michon, et al.
Pediatric Blood & Cancer
|
July 12, 2011
A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age
Sylvie Monnereau-Laborde, Caroline Munzer, Dominique Valteau-Couanet, et al.
Haematologica
|
March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study
Anne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
Pediatric Blood & Cancer
|
August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study
Cyril Lervat, Anne Auperin, Catherine Patte, et al.
Pediatric Blood & Cancer
|
October 24, 2020
Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome
Ida Russo, Christine Levy-Gabriel, Axelle Dupont, et al.
Pediatric Blood & Cancer
|
November 9, 2010
Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP)
Fousseyni Traoré, Carole Coze, Jean-Jacques Atteby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2005
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol
Dominique Valteau-Couanet, Jean Michon, Andrée Boneu, et al.
Page
of 6